GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR. Journal Abstract

GEC-ESTRO recommendations for head & neck cancer brachytherapy (interventional radiotherapy): 2nd update with focus on HDR and PDR.

Publication Date: 2024 Sep 14

Full Text Sources

Authors

J L Guinot; W Bacorro; A Budrukkar; F Bussu; V Gonzalez-Perez; R Jaberi; R Martinez-Monge; A Rembielak; A Rovirosa; V Strnad; Z Takácsi-Nagy; L Tagliaferri

Abstract

OBJECTIVE

Modern brachytherapy (BT) is playing an important role in the multidisciplinary treatment of Head and Neck (H&N) cancer, as an organ- and function-preserving therapy. Low-dose-rate (LDR) technology has been replaced by modern remote afterloading and stepping source equipment using pulsed dose rate (PDR) or high dose rate (HDR) sources, improved image guidance and 3D treatment planning systems. This is an update of the previous GEC-ESTRO recommendations for H&N tumors, mainly applied to squamous carcinomas. Indications, results and recommended doses for different tumor sites are presented according to the published studies.

Source

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Pub Types(s)

Journal Article

Language

English

PubMed ID

39284416